循环肿瘤标志物的临床实用性
本文综述了循环肿瘤标志物在常见上皮性肿瘤中的临床应用价值。肿瘤标志物可由癌细胞释放,也可由健康组织表达,健康人血浆和血清中可存在极低浓度。癌症患者水平常升高且与肿瘤负荷相关,但良性疾病可出现假阳性,正确解读需考虑分析前条件和患者并发疾病等因素。
要点
- 肿瘤标志物在健康人中可存在极低浓度,良性疾病可出现假阳性。
- 肿瘤标志物水平升高常与肿瘤负荷相关,但解读需结合分析前条件与并发疾病。
- 肿瘤标志物可用于辅助诊断、预后评估、复发早期检测和治疗反应监测。
核心结论
- 肿瘤标志物测量可为不同临床情境下的癌症患者管理提供有价值信息。
研究设计与样本
- 综述,分析基于近期证据和指南,聚焦最常见上皮性肿瘤中肿瘤标志物的临床应用。
主要发现
- 肿瘤标志物是癌细胞释放入血的一组异质性物质,健康组织也可表达,健康人血浆和血清中可存在极低浓度。
- 癌症患者肿瘤标志物水平常升高且与肿瘤负荷相关,良性疾病患者可出现假阳性结果。
- 肿瘤标志物测量有助于辅助诊断、估计预后、促进复发早期检测和监测治疗反应。
临床怎么用
- 解读肿瘤标志物结果需综合考虑分析前条件和患者并发疾病等因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tumor markers are a heterogeneous group of substances released by cancer cells into bloodstream, but also expressed by healthy tissues. Thus, very small concentrations can be present in plasma and serum from healthy subjects. Cancer patients tend to show increased levels correlating with tumor bulk, but false positive results could be present in patients with benign conditions. The correct interpretation of TM results could be challenging and many factors should be considered, from pre-analytical conditions to patient concomitant diseases. In this line, the Clinical Chemistry and Laboratory Medicine journal has made important contributions though several publications promoting the adequate use of TM and therefore improving patient safety. TM measurement offers valuable information for cancer patient management in different clinical contexts, such as helping diagnosis, estimating prognosis, facilitating early detection of relapse and monitoring therapy response. Our review analyzes the clinical usefulness of tumor markers applied in most frequent epithelial tumors, based on recent evidence and guidelines.
引用
- Filella X, Rodríguez-Garcia M, Fernández-Galán E, et al. Clinical usefulness of circulating tumor markers. Clin Chem Lab Med. 2022. PMID: 36394981. doi:10.1515/cclm-2022-1090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。